Pancreatic Cancer Research

ResearcherUniversitat Autònoma de BarcelonaActive in the last 2 years

Elizabeth Pando

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-6898-5502; OpenAlex author ID A5015250728. Sources: OpenAlex.

Their work

Papers
15 (first author 2, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
101
Papers, trials and grants by year

2020: 1 paper · 2021: 1 paper · 2022: none · 2023: 4 papers · 2024: 1 paper · 2025: 4 papers · 2026: 4 papers

Papers 15

  1. Radiofrequency Ablation and Chemotherapy vs Chemotherapy Only in Locally Advanced Pancreatic Cancer: The PELICAN Randomized Clinical Trial. Co-author DOI 10.1001/jamanetworkopen.2026.3861↗
  2. Consensus-based validation of key quality indicators in pancreatic cancer surgery in Catalonia: a modified Delphi study. Co-author DOI 10.1016/j.cireng.2026.800304↗
  3. Utility of archived EUS-guided fine-needle biopsy samples for next-generation sequencing in pancreatic adenocarcinoma. Last author DOI 10.1097/eus.0000000000000197↗
  4. Futility in adenosquamous pancreatic cancer. Co-author DOI 10.1186/s12957-026-04351-1↗
  5. Routine Imaging or Symptomatic Follow-Up After Resection of Pancreatic Adenocarcinoma. Co-author DOI 10.1001/jamasurg.2024.5024↗
  6. The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter study. Co-author DOI 10.1016/j.annonc.2024.12.015↗
  7. Patterns, timing and predictors of recurrence following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: an international multicentre retrospectiv… Co-author DOI 10.1016/j.hpb.2024.11.015↗
  8. Venous Resection During Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma-A Multicentre Propensity Score Matching Analysis of the Recurrence After Whi… Co-author DOI 10.3390/cancers17071223↗
  9. Five-year recurrence/survival after pancreatoduodenectomy for pancreatic adenocarcinoma: does pre-existing diabetes matter? Results from the Recurrence After W… Co-author DOI 10.1016/j.hpb.2024.04.010↗
  10. Assessment of the level III of Inoue by preoperative endoscopic ultrasound and elastography: a novel approach to predict a periarterial divestment technique in… First author DOI 10.1007/s00423-023-03105-x↗
  11. Liquid biopsy after resection of pancreatic adenocarcinoma and its relation to oncological outcomes. Systematic review and meta-analysis. First author DOI 10.1016/j.ctrv.2023.102604↗
  12. Robot-Assisted Versus Laparoscopic Distal Pancreatectomy in Patients with Resectable Pancreatic Cancer: An International, Retrospective, Cohort Study. Co-author DOI 10.1245/s10434-022-13054-2↗
  13. Does an extensive diagnostic workup for upfront resectable pancreatic cancer result in a delay which affects survival? Results from an international multicentr… Co-author DOI 10.14701/ahbps.23-042↗
  14. Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled… Co-author DOI 10.1186/s13063-021-05248-y↗
  15. Is the involvement of the hepatic artery lymph node a poor prognostic factor in pancreatic adenocarcinoma? Co-author DOI 10.1016/j.ciresp.2019.09.015↗

Closest collaborators

The 25 strongest of 101 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Teresa Mercade Macarulla · 3 shared papers, 2023–2026 · strength 0.60
  2. Fernando Burdı́o · 3 shared papers, 2023–2026 · strength 0.53
  3. Fabio Ausania · 3 shared papers, 2023–2026 · strength 0.52
  4. Ramón Charco · 3 shared papers, 2020–2023 · strength 0.47
  5. Santiago Sánchez-Cabús · 2 shared papers, 2026 · strength 0.42
  6. Juli Busquets · 2 shared papers, 2026 · strength 0.42
  7. Piero Alberti · 2 shared papers, 2023–2026 · strength 0.42
  8. Florian Castet · 2 shared papers, 2023–2026 · strength 0.41
  9. Ana P. Vivancos · 2 shared papers, 2023–2026 · strength 0.41
  10. Patricia Sánchez‐Velázquez · 2 shared papers, 2023–2026 · strength 0.35
  11. María Teresa Salcedo · 2 shared papers, 2020–2026 · strength 0.34
  12. Bergþór Björnsson · 2 shared papers, 2023–2026 · strength 0.29
  13. Alessandro Zerbi · 2 shared papers, 2023–2026 · strength 0.29
  14. Duncan R.C. Spalding · 2 shared papers, 2023–2025 · strength 0.28
  15. Alberto Porcu · 2 shared papers, 2023–2025 · strength 0.28
  16. Thomas Brendon Russell · 2 shared papers, 2023–2025 · strength 0.28
  17. Ricky Harminder Bhogal · 2 shared papers, 2023–2025 · strength 0.28
  18. Somaiah Aroori · 2 shared papers, 2023–2025 · strength 0.28
  19. Ismael Domínguez-Rosado · 2 shared papers, 2023–2025 · strength 0.28
  20. Dhanny Gomez · 2 shared papers, 2023–2025 · strength 0.28
  21. Brian Ritchie Davidson · 2 shared papers, 2023–2025 · strength 0.28
  22. Manuel Maglione · 2 shared papers, 2023–2025 · strength 0.28
  23. Keith John Roberts · 2 shared papers, 2023–2025 · strength 0.28
  24. Peter Lawrence Zaki Labib · 2 shared papers, 2023–2025 · strength 0.28
  25. Andrew Malvern Smith · 2 shared papers, 2023–2025 · strength 0.28

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.